US2009131316A1PendingUtilityA1
Glucagon-like peptide-1 secretagogue, glucagon-like peptide-1 secretagogue food or drink, inhibitor of postprandial rise in blood glucose, and inhibitory food or drink of postprandial rise in blood glucose
Assignee: MORINAGA MILK INDUSTRY CO LTDPriority: Sep 30, 2005Filed: Sep 29, 2006Published: May 21, 2009
Est. expirySep 30, 2025(expired)· nominal 20-yr term from priority
A23L 2/52A61P 3/08A23J 1/202A61K 38/012A61P 3/10A23V 2002/00A61P 5/50A61K 38/17A61K 38/26A61P 43/00A23L 33/19A61K 38/16A61K 47/26
62
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention relates to a GLP-1 secretagogue and an inhibitor of postprandial rise in blood glucose, containing κ-casein as an active ingredient, and a food or drink for promoting GLP-1 secretion and an inhibitory food or drink of postprandial rise in blood glucose, containing a milk-derived casein protein wherein κ-casein accounts for 60% by mass or more of the milk-derived casein.
Claims
exact text as granted — not AI-modified1 . A glucagon-like peptide-1 secretagogue, comprising κ-casein as an active ingredient.
2 . A glucagon-like peptide-1 secretagogue food or drink, comprising a milk-derived casein protein, wherein κ-casein accounts for 60% by mass or more of the milk-derived casein protein.
3 . The glucagon-like peptide-1 secretagogue food or drink according to claim 2 , further comprising a carbohydrate.
4 . An inhibitor of postprandial rise in blood glucose, comprising κ-casein as an active ingredient.
5 . An inhibitory food or drink of postprandial rise in blood glucose, comprising a milk-derived casein protein, wherein κ-casein accounts for 60% by mass or more of the milk-derived casein protein.
6 . The inhibitory food or drink of postprandial rise in blood glucose according to claim 5 , further comprising a carbohydrate.Join the waitlist — get patent alerts
Track US2009131316A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.